Neurocrine repurchases $31.4M of 2.25% Convertible Notes due 2024 for $41.5M

NEUROCRINE BIOSCIENCES INC

Repurchased ~$31.4M principal of 2024 Convertible Notes for ~$41.5M including accrued interest.
Transactions entered on May 31, 2022; closing expected June 2, 2022.
Repurchases are in addition to those disclosed in May 25, 2022 Form 8-K.
Company notes repurchases could affect common stock market price.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.